Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies?

被引：9
作者：
Atzeni, Fabiola [1 ]
Svenungsson, Elisabet [2 ]
Nurmohamed, Michael T. [3 ,4 ]
机构：
[1] Univ Messina, Rheumatol Unit, Messina, Italy
[2] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Div Rheumatol, S-17172 Stockholm, Sweden
[3] Vrije Univ Amsterdam Med Ctr, Amsterdam Univ Med Ctr, Amsterdam Rheumatol Immunol Ctr, Amsterdam, Netherlands
[4] Reade Rheumatol, Amsterdam, Netherlands
来源：
AUTOIMMUNITY REVIEWS | 2019年 / 18卷 / 12期
关键词：
Rheumatoid arthritis; Inflammatory arthropathies; Cardiovascular disease; Disease modifying antirheumatic drugs (DMARDS); Biologic treatment; SEROPOSITIVE RHEUMATOID-ARTHRITIS; CONGESTIVE-HEART-FAILURE; NECROSIS-FACTOR-ALPHA; MYOCARDIAL-INFARCTION; EXCESS MORTALITY; LIPID PROFILE; THERAPY; RISK; IMPROVEMENT; COHORT;
D O I：
10.1016/j.autrev.2019.102401
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页数：5
相关论文
共 46 条
[1]   Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink [J].
Abhishek, Abhishek ;
Nakafero, Georgina ;
Kuo, Chang-Fu ;
Mallen, Christian ;
Zhang, Weiya ;
Grainge, Matthew J. ;
Doherty, Michael .
RHEUMATOLOGY, 2018, 57 (06) :977-981
[2]   EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update [J].
Agca, R. ;
Heslinga, S. C. ;
Rollefstad, S. ;
Heslinga, M. ;
McInnes, B. ;
Peters, M. J. L. ;
Kvien, T. K. ;
Dougados, M. ;
Radner, H. ;
Atzeni, F. ;
Primdahl, J. ;
Sodergren, A. ;
Jonsson, S. Wallberg ;
van Rompay, J. ;
Zabalan, C. ;
Pedersen, T. R. ;
Jacobsson, L. ;
de Vlam, K. ;
Gonzalez-Gay, M. A. ;
Semb, A. G. ;
Kitas, G. D. ;
Smulders, Y. M. ;
Szekanecz, Z. ;
Sattar, N. ;
Symmons, D. P. M. ;
Nurmohamed, M. T. .
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) :17-28
[3]   Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial [J].
Ajeganova, Sofia ;
Svensson, Bjorn ;
Hafstrom, Ingiald .
BMJ OPEN, 2014, 4 (04)
[4]  
Alpha S., 2017, OLUMIANT CLOT SIGNAL
[5]   Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years [J].
Avouac, Jerome ;
Amrouche, Fazia ;
Meune, Christophe ;
Rey, Gregoire ;
Kahan, Andre ;
Allanore, Yannick .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (05) :537-543
[6]  
Benucci M, 2013, CLIN EXP RHEUMATOL, V31, P322
[7]   Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis [J].
Benucci, Maurizio ;
Saviola, Gianantonio ;
Manfredi, Mariangela ;
Sarzi-Puttini, Piercarlo ;
Atzeni, Fabiola .
BIOLOGICS-TARGETS & THERAPY, 2013, 7 :69-75
[8]   Trends in the epidemiology of cardiovascular disease in the UK [J].
Bhatnagar, Prachi ;
Wickramasinghe, Kremlin ;
Wilkins, Elizabeth ;
Townsend, Nick .
HEART, 2016, 102 (24) :1945-1952
[9]   Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist [J].
Charles-Schoeman, Christina ;
Gonzalez-Gay, Miguel A. ;
Kaplan, Irina ;
Boy, Mary ;
Geier, Jamie ;
Luo, Zhen ;
Zuckerman, Andrea ;
Riese, Richard .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 46 (01) :71-80
[10]   Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial [J].
Charles-Schoeman, Christina ;
Wang, Xiaoyan ;
Lee, Yuen Yin ;
Shahbazian, Ani ;
Navarro-Millan, Iris ;
Yang, Shuo ;
Chen, Lang ;
Cofield, Stacey S. ;
Moreland, Larry W. ;
O'Dell, James ;
Bathon, Joan M. ;
Paulus, Harold ;
Bridges, S. Louis, Jr. ;
Curtis, Jeffrey R. .
ARTHRITIS & RHEUMATOLOGY, 2016, 68 (03) :577-586
12345